Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
Conditions: Lung Transplant; Hepatitis B Intervention: Drug: Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide Sponsor: University of Pennsylvania Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Gammagard Liquid | Hepatitis | Hepatitis B | Hepatitis Vaccine | Lung Transplant | Privigen | Research | Transplant Surgery | Transplants | Vaccines | Viread